Celonis
Director of Sales
Building the AI-powered deal acceleration infrastructure to compress 9-month sales cycles and deliver IPO-ready revenue predictability — filling the CRO vacancy gap during a critical GTM reorganization.
Celonis’s revenue risk is not product quality — it’s that the sales infrastructure has not been rebuilt for the IPO chapter. The CRO is gone. The GTM is being restructured. And the company needs Directors who can do two things simultaneously: compress a 9-month sales cycle using automated proof-of-value sequences, and translate process intelligence into CFO-level financial language without relying on technical champions. No traditional sales director can do both. What is needed is someone who can build AI-powered deal acceleration infrastructure — automated ROI modeling, multi-stakeholder outreach coordination, proof-of-value sequencing — while simultaneously coaching a team to sell to the C-suite in margin language, not mining language. Every quarter that cycle times stay at 9 months is a quarter of revenue that misses the IPO window.
$22M North America closed ARR
$32M North America closed ARR
$45M — if the 90-day proof-of-value methodology achieves broad adoption and IPO creates a demand surge
Core Opportunity
Celonis is the dominant process mining platform at $11–$13B valuation with IPO expected in 2026, but the CRO has departed, GTM is being restructured, and 9-month sales cycles are dragging on the pre-IPO revenue story. Cost discipline means they need efficiency multipliers, not headcount.
Execution Thesis
Deploy AI-powered deal acceleration — automated ROI modeling, proof-of-value sequencing, multi-stakeholder coordination, and competitive displacement automation — to compress sales cycles from 9 months to under 90 days and deliver $22M–$45M in North America closed ARR with IPO-grade forecast accuracy.
Production systems, not theory. Revenue captured, not demos given.